PMV Pharmaceuticals, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
PMV Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2018 to 2023.
  • PMV Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $2.22M, a 33.1% decline year-over-year.
  • PMV Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $10.6M, a 15.2% decline year-over-year.
  • PMV Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $12.4M, a 21.4% increase from 2022.
  • PMV Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $10.2M, a 90.9% increase from 2021.
  • PMV Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $5.34M, a 176% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $12.4M +$2.18M +21.4% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 $10.2M +$4.86M +90.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 $5.34M +$3.41M +176% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2020 $1.93M +$1.03M +113% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2019 $908K -$171K -15.8% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 $1.08M Jan 1, 2018 Dec 31, 2018 10-K 2021-03-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.